Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

InMed Pharmaceuticals Inc. (INM)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-K10-Q10-Q10-K10-Q10-Q10-Q10-K
Sales  3.71.00.30.50.30.3 0.9
            Sales growth  614.3%234.0% -41.5%-29.2%-4.2%  
Cost of sales  1.00.80.20.30.10.20.1 
   
Inventory write-down          
    Gross profit  1.60.2-0.50.20.20.1  
            Gross margin  42.7%18.6%-153.1%48.5%58.9%42.1%  
   
Operating Expenses          
Research and development and patents  0.60.91.41.51.82.51.51.7
General and administrative  1.41.41.61.71.91.81.41.6
Amortization and depreciation  0.10.10.00.10.10.00.00.0
    Total operating expenses  12.92.33.024.93.74.42.93.3
   
Other Income (Expense)          
Interest and other income  0.10.20.10.00.00.00.00.0
Warrant modification expense     -1.3    
   
Foreign exchange loss          
    Loss before income tax expense  -0.3-2.0-3.5-7.9-3.5 -3.0 
    Net loss for the year  -0.3-2.0-3.5-7.9-3.5-4.3-3.0-3.3
   
Net loss per share for the year          
Basic and diluted (in Dollars per share)  $0.28($0.60)($4.06)($13.04)($6.14)($0.31)($6.17)($37.96)
   
Weighted average outstanding common shares          
Basic and diluted (in Shares)  2.43.30.90.60.613.80.50.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy